BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

971 related articles for article (PubMed ID: 15680923)

  • 21. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression, purification, and physical properties of recombinant flavocytochrome fusion proteins containing rat cytochrome b(5) linked to NADPH-cytochrome P450 reductase by different membrane-binding segments.
    Gilep AA; Guryev OL; Usanov SA; Estabrook RW
    Arch Biochem Biophys; 2001 Jun; 390(2):222-34. PubMed ID: 11396925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties.
    Parikh A; Josephy PD; Guengerich FP
    Biochemistry; 1999 Apr; 38(17):5283-9. PubMed ID: 10220313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optical biosensor study of ternary complex formation in a cytochrome P4502B4 system.
    Ivanov YD; Kanaeva IP; Archakov AI
    Biochem Biophys Res Commun; 2000 Jul; 273(2):750-2. PubMed ID: 10873675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression, purification, and characterization of a catalytically active human cytochrome P450 1A2:rat NADPH-cytochrome P450 reductase fusion protein.
    Parikh A; Guengerich FP
    Protein Expr Purif; 1997 Apr; 9(3):346-54. PubMed ID: 9126606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast.
    Hayashi K; Sakaki T; Kominami S; Inouye K; Yabusaki Y
    Arch Biochem Biophys; 2000 Sep; 381(1):164-70. PubMed ID: 11019832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterologous expression of an endogenous rat cytochrome b(5)/cytochrome b(5) reductase fusion protein: identification of histidines 62 and 85 as the heme axial ligands.
    Davis CA; Dhawan IK; Johnson MK; Barber MJ
    Arch Biochem Biophys; 2002 Apr; 400(1):63-75. PubMed ID: 11913972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate.
    Loughran PA; Roman LJ; Miller RT; Masters BS
    Arch Biochem Biophys; 2001 Jan; 385(2):311-21. PubMed ID: 11368012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The optical biosensor studies on the role of hydrophobic tails of NADPH-cytochrome P450 reductase and cytochromes P450 2B4 and b5 upon productive complex formation within a monomeric reconstituted system.
    Ivanov YD; Kanaeva IP; Kuznetsov VY; Lehnerer M; Schulze J; Hlavica P; Archakov AI
    Arch Biochem Biophys; 1999 Feb; 362(1):87-93. PubMed ID: 9917332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug metabolism by Escherichia coli expressing human cytochromes P450.
    Parikh A; Gillam EM; Guengerich FP
    Nat Biotechnol; 1997 Aug; 15(8):784-8. PubMed ID: 9255795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 reductase system and studies with apo-cytochrome b5.
    Yamazaki H; Johnson WW; Ueng YF; Shimada T; Guengerich FP
    J Biol Chem; 1996 Nov; 271(44):27438-44. PubMed ID: 8910324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An enzymatically active chimeric protein containing the hydrophilic form of NADPH-cytochrome P450 reductase fused to the membrane-binding domain of cytochrome b5.
    Gilep AA; Guryev OL; Usanov SA; Estabrook RW
    Biochem Biophys Res Commun; 2001 Jun; 284(4):937-41. PubMed ID: 11409883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
    Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
    Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
    Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
    Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
    Guengerich FP; Johnson WW
    Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.
    Tan Y; Patten CJ; Smith T; Yang CS
    Arch Biochem Biophys; 1997 Jun; 342(1):82-91. PubMed ID: 9185616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of putidaredoxin reductase from Pseudomonas putida, the final structural component of the cytochrome P450cam monooxygenase.
    Sevrioukova IF; Li H; Poulos TL
    J Mol Biol; 2004 Feb; 336(4):889-902. PubMed ID: 15095867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of benzyl isothiocyanate on rat and human cytochromes P450: identification of metabolites formed by P450 2B1.
    Goosen TC; Mills DE; Hollenberg PF
    J Pharmacol Exp Ther; 2001 Jan; 296(1):198-206. PubMed ID: 11123381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of cytochrome P450 2E1 by benzyl isothiocyanate.
    Moreno RL; Kent UM; Hodge K; Hollenberg PF
    Chem Res Toxicol; 1999 Jul; 12(7):582-7. PubMed ID: 10409397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of multiple forms of cytochrome P450 from a human brain and reconstitution of catalytic activities.
    Bhamre S; Anandatheerathavarada HK; Shankar SK; Boyd MR; Ravindranath V
    Arch Biochem Biophys; 1993 Mar; 301(2):251-5. PubMed ID: 8460938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.